Latent transforming growth factor β-binding protein-3 and fibulin-I C interact with the extracellular domain of the heparin-binding EGF-like growth factor precursor

BMC Cell Biology

Volumn 3, Issue , 2002, Pages

  Brooke, Joanna S ^a   Cha, Jeong Heon ^b   Eidels, Leon ^b  

^a DEPAUL UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CALCIUM; COMPLEMENTARY DNA; FIBULIN; FIBULIN 1 C; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 3; NUCLEOTIDE; PROTEIN PRECURSOR; SCLEROPROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM BINDING; CELL SURFACE; CONTROLLED STUDY; DNA LIBRARY; EXTRACELLULAR MATRIX; GENETIC CODE; GENETIC SCREENING; KIDNEY; MOLECULAR CLONING; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TWO HYBRID SYSTEM; YEAST;

EID: 2342668039     PISSN: 14712121     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2121-3-2     Document Type: Article

References (52)

1. Davis-Fleischer KM, Besner GE: Structure and function of heparin-binding EGF-like growth factor (HB-EGF). Frontiers in Bioscience 1998, 3:d288-299
2. Naglich JG, Metherall JE, Russell DW, Eidels L: Expression cloning of diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992, 69:1051-1061
3. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M: A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991, 251:936-939
4. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M: Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 1992, 267:6205-6212
5. Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N: Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtracrine to paracrine growth factor activity. Mo. Biol Cell 1995, 6:967-980
6. Carpenter G, Wahl MI: The epidermal growth factor family. In: Handbook of Experimental Pharmacology (Edited by Sporn MB, Roberts AB) New York, Springer-Verlag 1990, 95:69-171
7. Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E: The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol 1995, 128:929-938
8. Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E: Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J 1994, 13:2322-2330
9. Cha JH, Brooke JS, Ivey KN, Eidels L: Cell surface monkey CD9 antigen is a coreceptor that increases diphtheria toxin sensitivity and diphtheria toxin receptor affinity. J Biol 2000, 275:6901-6907
10. Bignon C, Sakal E, Belair L, Chapnik-Cohen N, Djiane J, Gertlerk A: Preparation of the extracellular domain of the rabbit prolactin receptor expressed in Escherichia coli and its interaction with lactogenic hormones. J Biol Chem 1994, 269:3318-3324
11. Pẗgens AJG, Hk Lubsen N, van Altena MC, Vermeulen R, Bakker A, Schoenmakers JGG, Ruiter DJ, de Waal RMW: Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. J Biol Chem 1994, 269:32879-32885
12. Terman BI, Cougher-Vermanzen M, Carrion ME, Dimitrov D, Armellina DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Comm 1992, 187:1579-1586
13. Vaisman N, Gospodarowicz D, Neufeld G: Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 1990, 265:19461-19466
14. Wright MD, Tomlinson MG: The ins and outs of the transmembrane 4 superfamily. Immunol Today 1994, 15:588-594
15. Maecker HT, Todd SC, Levy S: The tetraspanin superfamily: molecular facilitators. FASEB J 1997, 11:428-442
16. Bulus N, Barnard JA: Heparin binding epidermal growth factor-like growth factor is a transforming growth factor β -regulated gene in intestinal epithelial cells. Biochem Biophys Res Commun 1999, 264:808-812
17. Pereira L, D'Alessio M, Ramirez F, Lynch JR, Sykes B, Pangilinan T, Bonadio J: Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Human Mol Genet 1993, 2:961-968
18. Yin W, Smiley E, Germiller J, Mecham RP, Florer JB, Wenstrup RJ, Bonadio J: Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J Biol Chem 1995, 270:10147-10160
19. Mayer U, Nischt R, Posehl E, Mann K, Fukuda K, Gerl M, Yamada Y, Timpl R: A single EGF-like motif of laminin is responsible for high affinity nidogen binding. EMBO J 1993, 12:1879-1885
20. Handford P, Downing AK, Rhao Z, Hewett DR, Sykes BC, Kielty CM: The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1. J Biol Chem 1995, 270:6751-6756
21. Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID, Handford PA: Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 1996, 85:597-605
22. Thompson SA, Higashiyama S, Wood K, Pollitt NS, Damm D, McEnroe G, Garrick B, Ashton N, Lau K, Hancock N, Klagsbrun M, Abraham JA: Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. J Biol Chem 1994, 269:2541-2549
23. Miyazono K, Olofsson A, Colosetti P, Heldin CH: A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 1991, 5:1091-1101
24. Lyons RM, Keski-Oja J, Moses HL: Proteolytic activation of latent transforming growth factor-β from fibroblast conditioned medium. J Cell Biol 1988, 106:1597-1605
25. Ignotz RA, Massague J: Transforming growth factor-β stimulates expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986, 261:4337-4345
26. Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen WT, Yamada KM, McDonald JA: Transforming growth factor P stimulates expression of fibronectin and both subunits of the human fibronectin receptor by cultures of human lung fibroblasts. J Biol Chem 1988, 263:4586-4592
27. Penttinen RP, Kobayashi S, Bornstein P: Transforming growth factor P increased mRNA for matrix proteins both in the presence and absence of changes in mRNA stability. Proc Natl Acad Sci USA 1988, 85:1105-1108
28. McKay NG, Khong TF, Haites NE, Power DA: The effect of transforming growth factor beta 1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but not effect on alternative splicing. Exp Mol Pathol 1993, 59:211-224
29. Marigo V, Volphin D, Vitale G, Bressn GM: Identification of a TGF-β responsive element in the human elastin promoter. Biochem Biophys Res Commun 1994, 199:1049-1056
30. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, DeCrombrugghe B: A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 1988, 52:405-414
31. Koli K, Lohi J, Hautanen A, Keski-Oja J: Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-β1. Eur J Biochem 1991, 199:337-345
32. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R: cDNA cloning and induction by TGF-β. EMBO J 1988, 7:2677-2681
33. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty JP, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloprotease inhibitor. EMBO J 1987, 6:1899-1904
34. Kubota S, Fridman R, Yamada Y: Transforming growth factor β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease. Biochem Biophys Res Comm 1991, 176:129-136
35. Tomooka S, Border WA, Marshall BO, Noble WA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 1992, 42:1462-1469
36. Laiho M, Saksela O, Keski-Oja J: Transforming growth factor-β induction of type-I plasminogen activator inhibitor. J Biol Chem 1987, 262:17467-17474
37. Argraves WS, Tran H, Burgess WH, Dickerson K: Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol 1990, 111:3155-3164
38. Kluge M, Mann K, Dziadek M, Timpl R: Characterization of a novel calcium-binding 90-kDa glycoprotein (BM-90) shared by basement membranes and serum. Eur J 1990, 193:651-659
39. Pan TC, Kluge M, Zhang RZ, Mayer U, Timpl R, Chu ML: Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement membrane ligands. Eur J Biochem 1993, 215:733-740
40. Balbona K, Tran H, Godyna S, Ingham KC, Strickland DK, Argraves WS: Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin. J Biol Chem 1992, 267:20120-20125
41. Aspberg A, Adam S, Kostka G, Timpl R, Heinegard D: Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem 1999, 274:20444-20449
42. Adam S, Göhring W, Wiedemann H, Chu ML, Timpl R, Kostka G: Binding of fibulin-1 to nidogen depends on its C-terminal globular domain and a specific array of calcium-binding epidermal growth factor-like (EG) modules. J Mol Biol 1997, 272:226-236
43. McKeown-Longo PJ: Fibronectin-cell surface interactions. Rev Infect Dis 1987, 9:S322-S334
44. Tran H, VanDusen WJ, Argraves WS: The self-association and fibronectin-binding sites of fibulin-1 map to calcium-binding epidermal growth factor-like domains. J Biol Chem 1997, 272:22600-22606
45. Sasaki M, Kleinman HK, Huber H, Deutzmann R, Yamada Y: Laminin, a multidomain protein. J Biol Chem 1988, 263:16536-16544
46. Brown JC, Wiedemann H, Timpl R: Protein binding and cell adhesion properties of two laminin isoforms (AmB1eB2e, AmB1sB2e) from human placenta. J Cell Science 1994, 107:329-338
47. Reinhardt D, Mann K, Nischt R, Fox JW, Chu ML, Krieg T, Timpl R: Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J Biol Chem 1993, 268:10881-10887
48. Ries A, Gohring W, Fox JW, Timpl R, Sasaki T: Recombinant domains of mouse nidogen-1 and their binding to basement membrane proteins and monoclonal antibodies. Eur J Biochem 2001, 268:5119-5128
49. Wight TN, Heinegard DK, Hascall VC: Proteoglycans: structure and function. In: Cell Biology of Extracellular Matrix 199145-78
50. Izzo RV, Murdoch AD: Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel properties in molecular diversity and function. FASEB J 1996, 10:598-614
51. Godyna S, Mann DM, Argraves WS: A quantitative analysis of the incorporation of fibulin-1 into extracellular matrix indicates that fibronectin assembly is required. Matrix Biol 1994, 14:467-477
52. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: A laboratory manual. Cold Spring Harbor, Cold Spring Harbor Press 1989